Recurrent hepatocellular carcinoma is a problem we need to tackle: Comments

Liver Transplantation

Volumn 13, Issue 7, 2007, Pages 1057-1061

  Perkins, James D ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CD147 ANTIGEN; CYCLOSPORIN A; LICARTIN; METUXIMAB I 131; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; CADAVER DONOR; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG TARGETING; ECHOGRAPHY; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SHORT SURVEY; SURVIVAL RATE; ADRENERGIC SYSTEM; CARDIOMYOPATHY; CHRONOTROPISM; CIRRHOTIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; DISEASE ACTIVITY; DOWN REGULATION; HEART ATRIUM PRESSURE; HEART OUTPUT; HIGH OUTPUT HEART FAILURE; INOTROPISM; LIVER CIRRHOSIS; LUNG ARTERY PRESSURE; MYOCARDIAL DISEASE; PERITONEUM VEIN SHUNT; PORTOSYSTEMIC ANASTOMOSIS; SYSTOLIC DYSFUNCTION;

EID: 34547508338     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21218     Document Type: Short Survey

References (6)

1. Onaca N, Davis GL, Goldstein RK Jennings LW, Klintmalm GB. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007;13:391-399.
2. Shah SA, Tan JC, McGilvray ID, Cattral MS, Cleary SP, Levy GA, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2006;81:1633-1639.
3. Reddy MS, Manas DM. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma. Transplantation 2007;83:367-368.
4. Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG, et al. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl 2007; 13:543-551.
5. Zhou J, Fan J, Wang Z, Wu ZQ, Qiu SJ, Huang XW, et al. Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: report of an initial experience. World J Gastroenterol 2006;12:3114-3118.
6. Chen ZN, Mi L, Xu J, Song F, Zhang Q, Zhang Z, et al Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (1311) metuximab injection: clinical phase I/II trials. Int J Radiat Oncol Biol Phys 2006;65: 435-444.